Lung Cancer Surgery Market Size, Share, Trends, Growth Outlook

Lung Cancer Surgery Market is estimated to increase at a Compounded Annual Growth Rate of 4.2% CAGR over the forecast period from 2024 to 2030

The Lung Cancer Surgery Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Surgical Devices (Surgical Instruments, Monitoring Devices, Endo surgical Equipment), By Surgical Procedures (Thoracotomy, Minimally Invasive Surgeries).

An Introduction to Lung Cancer Surgery Market in 2024

Lung cancer surgery encompasses a variety of surgical procedures used to treat lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), as well as other thoracic malignancies. In 2024, lung cancer surgery remains a cornerstone of treatment for early-stage and locally advanced lung cancer, offering curative options for eligible patients and palliative interventions to relieve symptoms and improve quality of life. Surgical approaches for lung cancer include lobectomy, segmentectomy, pneumonectomy, and wedge resection, depending on the tumor size, location, and stage, as well as patient factors such as pulmonary function and overall health status. Additionally, minimally invasive techniques such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery have become increasingly common, offering reduced postoperative pain, shorter hospital stays, and faster recovery times compared to traditional open surgery. As multidisciplinary treatment strategies and personalized medicine approaches continue to evolve, lung cancer surgery remains an integral component of comprehensive cancer care, providing patients with the best possible outcomes and quality of life while advancing our understanding of lung cancer biology and treatment modalities.

Market Trend: Shift Towards Minimally Invasive Surgical Techniques

A prominent trend in the lung cancer surgery market is the shift towards minimally invasive surgical techniques. Traditionally, lung cancer surgeries involved open thoracotomy procedures, which often led to significant postoperative pain, longer hospital stays, and slower recovery times. However, advancements in surgical technology and techniques, such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery, have revolutionized lung cancer treatment by offering minimally invasive alternatives. These approaches utilize small incisions and specialized instruments, allowing surgeons to perform precise resections while minimizing trauma to surrounding tissues. Patients undergoing minimally invasive lung cancer surgery experience reduced pain, shorter hospital stays, and faster recovery, driving the adoption of these techniques and reshaping the landscape of lung cancer surgery.

Market Driver: Rising Incidence of Lung Cancer and Improved Survival Rates

A key driver fueling the demand for lung cancer surgery is the rising incidence of lung cancer globally and the improved survival rates associated with surgical intervention. Lung cancer remains one of the leading causes of cancer-related mortality worldwide, with smoking, environmental pollutants, and genetic factors contributing to its prevalence. However, advancements in early detection methods, such as low-dose computed tomography (LDCT) screening, have enabled the diagnosis of lung cancer at earlier stages when surgical resection is more feasible and curative. Additionally, advancements in perioperative care, anesthesia techniques, and postoperative management have contributed to improved surgical outcomes and survival rates for patients undergoing lung cancer surgery. As efforts to improve lung cancer screening and treatment continue to evolve, the demand for surgical interventions as a cornerstone of curative treatment approaches is expected to increase, driving market growth.

Market Opportunity: Adoption of Enhanced Imaging and Navigation Technologies

A significant opportunity for the lung cancer surgery market lies in the adoption of enhanced imaging and navigation technologies to improve surgical outcomes and patient care. Innovations such as intraoperative imaging modalities, navigational bronchoscopy systems, and augmented reality-assisted surgery offer surgeons enhanced visualization and precision during lung cancer procedures. These technologies enable more accurate tumor localization, improved margin assessment, and better preservation of healthy lung tissue, ultimately leading to better oncologic outcomes and reduced complications. Additionally, the integration of artificial intelligence and machine learning algorithms into imaging and navigation systems holds the potential to further optimize surgical planning and intraoperative decision-making, enhancing the efficiency and safety of lung cancer surgeries. By embracing these advanced technologies, healthcare providers can capitalize on the opportunity to deliver state-of-the-art care and improve outcomes for patients undergoing lung cancer surgery.

Lung Cancer Surgery Market Share Analysis: Minimally Invasive Surgeries is the fastest growing segment over the forecast period to 2030

Among the segments listed, Minimally Invasive Surgeries are experiencing the most rapid growth in the Lung Cancer Surgery Market. This growth is driven by several key factors. Firstly, minimally invasive surgical techniques, such as video-assisted thoracic surgery (VATS) and robotic-assisted surgery, have revolutionized the field of lung cancer surgery by offering patients less invasive treatment options with reduced postoperative pain, shorter hospital stays, and faster recovery times compared to traditional open surgeries. VATS involves the use of small incisions and a thoracoscope to visualize and access the lung, allowing for precise resection of tumors while preserving healthy lung tissue. Robotic-assisted surgery enhances the surgeon's dexterity and visualization capabilities, enabling more complex and precise surgical maneuvers with improved outcomes. Secondly, advancements in surgical instrumentation, imaging technology, and surgical techniques have expanded the feasibility and safety of minimally invasive lung cancer surgeries. Innovations such as 3D high-definition imaging, advanced energy devices, and articulated robotic arms have enhanced the surgeon's ability to navigate anatomical structures and perform intricate procedures with greater precision and control. Thirdly, the increasing adoption of lung cancer screening programs and the growing incidence of early-stage lung cancer detection have fueled the demand for minimally invasive surgical interventions, as these techniques offer curative treatment options for patients with localized disease who are not candidates for traditional open surgeries. Additionally, the preference for minimally invasive approaches among patients and healthcare providers, coupled with the expanding availability of robotic surgical systems and VATS training programs, has further contributed to the widespread adoption of minimally invasive lung cancer surgeries. With ongoing technological innovation, increasing surgical expertise, and favorable patient outcomes, minimally invasive surgeries are poised for continued rapid growth in the Lung Cancer Surgery Market.

Lung Cancer Surgery Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAccuray Inc, AngioDynamics Inc, Ethicon US LLC, Intuitive Surgical Inc, Key Surgical LLC, KLS Martin Group, Medtronic plc, Olympus Corp, Phoenix Surgical Holdings Ltd, Richard Wolf GmbH, Siemens Healthineers, Sontec Instruments Inc, Teleflex Inc, Wexler Surgical Inc

Lung Cancer Surgery Market Segmentation

By Surgical Devices
Surgical Instruments
Monitoring Devices
Endo surgical Equipment
By Surgical Procedures
Thoracotomy
-Lobectomy
-Sleeve Resection
-Segmentectomy
-Pnuemenectomy
Minimally Invasive Surgeries
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Lung Cancer Surgery Market Companies

Accuray Inc
AngioDynamics Inc
Ethicon US LLC
Intuitive Surgical Inc
Key Surgical LLC
KLS Martin Group
Medtronic plc
Olympus Corp
Phoenix Surgical Holdings Ltd
Richard Wolf GmbH
Siemens Healthineers
Sontec Instruments Inc
Teleflex Inc
Wexler Surgical Inc

Reasons to Buy the Lung Cancer Surgery Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Lung Cancer Surgery Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Lung Cancer Surgery Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Lung Cancer Surgery Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Lung Cancer Surgery Market Size Outlook, $ Million, 2021 to 2030
3.2 Lung Cancer Surgery Market Outlook by Type, $ Million, 2021 to 2030
3.3 Lung Cancer Surgery Market Outlook by Product, $ Million, 2021 to 2030
3.4 Lung Cancer Surgery Market Outlook by Application, $ Million, 2021 to 2030
3.5 Lung Cancer Surgery Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Lung Cancer Surgery Industry
4.2 Key Market Trends in Lung Cancer Surgery Industry
4.3 Potential Opportunities in Lung Cancer Surgery Industry
4.4 Key Challenges in Lung Cancer Surgery Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Lung Cancer Surgery Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Lung Cancer Surgery Market Outlook by Segments
7.1 Lung Cancer Surgery Market Outlook by Segments, $ Million, 2021- 2030
By Surgical Devices
Surgical Instruments
Monitoring Devices
Endo surgical Equipment
By Surgical Procedures
Thoracotomy
-Lobectomy
-Sleeve Resection
-Segmentectomy
-Pnuemenectomy
Minimally Invasive Surgeries

8 North America Lung Cancer Surgery Market Analysis and Outlook To 2030
8.1 Introduction to North America Lung Cancer Surgery Markets in 2024
8.2 North America Lung Cancer Surgery Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Lung Cancer Surgery Market size Outlook by Segments, 2021-2030
By Surgical Devices
Surgical Instruments
Monitoring Devices
Endo surgical Equipment
By Surgical Procedures
Thoracotomy
-Lobectomy
-Sleeve Resection
-Segmentectomy
-Pnuemenectomy
Minimally Invasive Surgeries

9 Europe Lung Cancer Surgery Market Analysis and Outlook To 2030
9.1 Introduction to Europe Lung Cancer Surgery Markets in 2024
9.2 Europe Lung Cancer Surgery Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Lung Cancer Surgery Market Size Outlook by Segments, 2021-2030
By Surgical Devices
Surgical Instruments
Monitoring Devices
Endo surgical Equipment
By Surgical Procedures
Thoracotomy
-Lobectomy
-Sleeve Resection
-Segmentectomy
-Pnuemenectomy
Minimally Invasive Surgeries

10 Asia Pacific Lung Cancer Surgery Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Lung Cancer Surgery Markets in 2024
10.2 Asia Pacific Lung Cancer Surgery Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Lung Cancer Surgery Market size Outlook by Segments, 2021-2030
By Surgical Devices
Surgical Instruments
Monitoring Devices
Endo surgical Equipment
By Surgical Procedures
Thoracotomy
-Lobectomy
-Sleeve Resection
-Segmentectomy
-Pnuemenectomy
Minimally Invasive Surgeries

11 South America Lung Cancer Surgery Market Analysis and Outlook To 2030
11.1 Introduction to South America Lung Cancer Surgery Markets in 2024
11.2 South America Lung Cancer Surgery Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Lung Cancer Surgery Market size Outlook by Segments, 2021-2030
By Surgical Devices
Surgical Instruments
Monitoring Devices
Endo surgical Equipment
By Surgical Procedures
Thoracotomy
-Lobectomy
-Sleeve Resection
-Segmentectomy
-Pnuemenectomy
Minimally Invasive Surgeries
12 Middle East and Africa Lung Cancer Surgery Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Lung Cancer Surgery Markets in 2024
12.2 Middle East and Africa Lung Cancer Surgery Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Lung Cancer Surgery Market size Outlook by Segments, 2021-2030
By Surgical Devices
Surgical Instruments
Monitoring Devices
Endo surgical Equipment
By Surgical Procedures
Thoracotomy
-Lobectomy
-Sleeve Resection
-Segmentectomy
-Pnuemenectomy
Minimally Invasive Surgeries

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Accuray Inc
AngioDynamics Inc
Ethicon US LLC
Intuitive Surgical Inc
Key Surgical LLC
KLS Martin Group
Medtronic plc
Olympus Corp
Phoenix Surgical Holdings Ltd
Richard Wolf GmbH
Siemens Healthineers
Sontec Instruments Inc
Teleflex Inc
Wexler Surgical Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Surgical Devices
Surgical Instruments
Monitoring Devices
Endo surgical Equipment
By Surgical Procedures
Thoracotomy
-Lobectomy
-Sleeve Resection
-Segmentectomy
-Pnuemenectomy
Minimally Invasive Surgeries
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)